Clinical Trials Browser

Phase 3 × Sorafenib × Breast × Clear all

NCT01234337 2018-11-06

Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 3 Completed

537 enrolled 24 charts

Breast Neoplasms